HPA

MARCH 15, 2022

We’re excited to share that metaMe Health , a prescription digital therapeutics (PDT) company, today announced raising $2.2M Ken Greisman , the HPA Deal Lead and a veteran of the pharmaceutical industry, has joined the metaMe board of directors. in funding. and chief legal officer at Takeda Pharmaceuticals U.S.A.,

health 113

health digital therapeutics board support 113

HPA

MARCH 15, 2022

We’re excited to share that metaMe Health , a prescription digital therapeutics (PDT) company, today announced raising $2.2M Ken Greisman , the HPA Deal Lead and a veteran of the pharmaceutical industry, has joined the metaMe board of directors. in funding. and chief legal officer at Takeda Pharmaceuticals U.S.A.,

health 91

health digital therapeutics board support 91

AsiaTechDaily

APRIL 30, 2022

Register Biofourmis , a Sigapore-founded digital therapeutics firm , announced that it has surpassed unicorn status with a $300 million Series D investment led by leading global growth equity firm General Atlantic. With this investment, Biofourmis plans to scale up its virtual care offerings, according to the announcement.

digital therapeutics 52

digital therapeutics health accelerator board 52

Angel Capital Association

MAY 18, 2020

MedRhythms, a Portland, Maine-based digital therapeutics company, is building direct stimulation, prescription therapeutics that use sensors, music, and software to improve loss of mobility caused by neurologic injuries and diseases. How does MedRhythms’ technology work?

digital therapeutics 40

digital therapeutics hospitality angel capital economic development 40